DA32 Life Science Tech Acquisition Corp. Class A Common Stock
DALS
DALS was delisted on the 28th of July, 2023.
36 hedge funds and large institutions have $162M invested in DA32 Life Science Tech Acquisition Corp. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 5 closing their positions.
20% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 5
3% more funds holding
Funds holding: 35 → 36 (+1)
1% less capital invested
Capital invested by funds: $163M → $162M (-$1.29M)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Sculptor Capital
New York
|
+$2.23M |
| 2 |
FIG
Fortress Investment Group
New York
|
+$1.68M |
| 3 |
EAM
Exos Asset Management
New York
|
+$721K |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$656K |
| 5 |
RIA
RP Investment Advisors
Toronto,
Ontario, Canada
|
+$532K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.93M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.24M |
| 3 |
PVI
Pura Vida Investments
New York
|
-$345K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$216K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$157K |
DALS Hedge Fund Activity: Q4 2021 in Review
36 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) for Q4 2021, worth a combined $162M — down 0.79% from $163M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new DALS positions and 5 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Sculptor Capital, adding an estimated $2.23M. The largest seller was Monashee Investment Management, exiting entirely with an estimated $3.93M sold.
- 36 institutional investors held DA32 Life Science Tech Acquisition Corp. Class A Common Stock (DALS) as of Q4 2021, up from 35 in Q3 2021.
- Funds reported $162M of DA32 Life Science Tech Acquisition Corp. Class A Common Stock stock for Q4 2021, down 0.79% quarter-over-quarter.
- 6 funds opened new DA32 Life Science Tech Acquisition Corp. Class A Common Stock positions in Q4 2021 and 5 closed out, a net change of +1 holder.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock buyer in Q4 2021 was Sculptor Capital, an estimated $2.23M added.
- The largest DA32 Life Science Tech Acquisition Corp. Class A Common Stock seller in Q4 2021 was Monashee Investment Management, an estimated $3.93M sold.
Based on aggregated 13F filings for Q4 2021.